IKNA insider filings

ImageneBio, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-07-30. Screen IKNA transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for IKNA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — ImageneBio, Inc.

FiledFormInsiderReported transactionsSource
2025-07-304ORBIMED ADVISORS LLC — Director
OrbiMed Capital GP VI LLC — Director
OrbiMed Genesis GP LLC — Director
Grant/award (A): 83,611 @ $2.49EDGAR
2024-06-104Koehler Maria — DirectorGrant/award (A): 17,520 (derivative) @ $0EDGAR
2024-06-104Wooster Richard — DirectorGrant/award (A): 17,520 (derivative) @ $0EDGAR
2024-06-104Dukes Iain D. — DirectorGrant/award (A): 17,520 (derivative) @ $0EDGAR
2024-06-104Hughes Owen — DirectorGrant/award (A): 17,520 (derivative) @ $0EDGAR
2024-06-104Bonita David P — DirectorGrant/award (A): 17,520 (derivative) @ $0EDGAR
2024-06-104Stampacchia Otello — DirectorGrant/award (A): 17,520 (derivative) @ $0EDGAR
2024-06-104FORMELA JEAN FRANCOIS — DirectorGrant/award (A): 17,520 (derivative) @ $0EDGAR
2024-03-054Germa Caroline — Chief Medical OfficerGrant/award (A): 579,100 (derivative) @ $0EDGAR
2024-02-024Ecsedy Jeffrey — Chief Development OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2024-02-024Manfredi Mark — President & CEO, DirectorGrant/award (A): 320,000 (derivative) @ $0EDGAR
2024-02-024Marango Jotin — CFO & Head of Corp. Dev.Grant/award (A): 181,000 (derivative) @ $0EDGAR
2023-09-214/ABonita David P — DirectorGrant/award (A): 153,121 · Grant/award (A): 353,192 (derivative)EDGAR
2023-09-214/AORBIMED ADVISORS LLC — Director
OrbiMed Capital GP VI LLC — Director
OrbiMed Genesis GP LLC — Director
Grant/award (A): 153,121 · Grant/award (A): 353,192 (derivative)EDGAR
2023-09-144Bonita David P — DirectorGrant/award (A): 153,121 · Grant/award (A): 353,192 (derivative)EDGAR
2023-09-144ORBIMED ADVISORS LLC — Director
OrbiMed Capital GP VI LLC — Director
OrbiMed Genesis GP LLC — Director
Grant/award (A): 153,121 · Grant/award (A): 353,192 (derivative)EDGAR
2023-06-134Koehler Maria — DirectorGrant/award (A): 17,520 (derivative) @ $0EDGAR
2023-06-134Wooster Richard — DirectorGrant/award (A): 17,520 (derivative) @ $0EDGAR
2023-06-134Dukes Iain D. — DirectorGrant/award (A): 17,520 (derivative) @ $0EDGAR
2023-06-134Hughes Owen — DirectorGrant/award (A): 17,520 (derivative) @ $0EDGAR
2023-06-134Bonita David P — DirectorGrant/award (A): 17,520 (derivative) @ $0EDGAR
2023-06-134Stampacchia Otello — DirectorGrant/award (A): 17,520 (derivative) @ $0EDGAR
2023-06-134FORMELA JEAN FRANCOIS — DirectorGrant/award (A): 17,520 (derivative) @ $0EDGAR
2023-01-054Ecsedy Jeffrey — Chief Development OfficerGrant/award (A): 105,000 (derivative) @ $0EDGAR
2023-01-054Zhang Xiaoyan Michelle — Chief Scientific OfficerGrant/award (A): 105,000 (derivative) @ $0EDGAR
2023-01-054Manfredi Mark — President & CEO, DirectorGrant/award (A): 220,000 (derivative) @ $0EDGAR
2023-01-054Marango Jotin — CFO & Head of Corp. Dev.Grant/award (A): 105,000 (derivative) @ $0EDGAR
2023-01-054Santillana Sergio L. — Chief Medical OfficerGrant/award (A): 105,000 (derivative) @ $0EDGAR
2022-12-194Hughes Owen — DirectorGrant/award (A): 35,040 (derivative) @ $0EDGAR
2022-06-244Bonita David P — DirectorPurchase (P): 66,806 @ $3.55 · Purchase (P): 23,419 @ $3.71 · Purchase (P): 65,965 @ $4.37 · Purchase (P): 96,035 @ $5.37EDGAR
2022-06-244ORBIMED ADVISORS LLC — Director
OrbiMed Capital GP VI LLC — Director
OrbiMed Genesis GP LLC — Director
Purchase (P): 66,806 @ $3.55 · Purchase (P): 23,419 @ $3.71 · Purchase (P): 65,965 @ $4.37 · Purchase (P): 96,035 @ $5.37EDGAR
2022-06-134Koehler Maria — DirectorGrant/award (A): 13,419 (derivative) @ $0EDGAR
2022-06-134Wooster Richard — DirectorGrant/award (A): 13,419 (derivative) @ $0EDGAR
2022-06-134Dukes Iain D. — DirectorGrant/award (A): 13,419 (derivative) @ $0EDGAR
2022-06-134Bonita David P — DirectorGrant/award (A): 13,419 (derivative) @ $0EDGAR
2022-06-134Stampacchia Otello — DirectorGrant/award (A): 13,419 (derivative) @ $0EDGAR
2022-06-134Renaud Ronald C JR — DirectorGrant/award (A): 13,419 (derivative) @ $0EDGAR
2022-06-134FORMELA JEAN FRANCOIS — DirectorGrant/award (A): 13,419 (derivative) @ $0EDGAR
2022-04-254Marango Jotin — CFO & Head of Corp. Dev.Grant/award (A): 397,199 (derivative) @ $0EDGAR
2022-02-044Zhang Xiaoyan Michelle — Chief Scientific OfficerGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-02-044Manfredi Mark — President & CEO, DirectorGrant/award (A): 238,900 (derivative) @ $0EDGAR
2022-02-044Ecsedy Jeffrey — Chief Development OfficerGrant/award (A): 59,360 (derivative) @ $0EDGAR
2022-02-044Tessier Maude — Chief Business OfficerGrant/award (A): 40,000 (derivative) @ $0EDGAR
2022-02-044Santillana Sergio L. — Chief Medical OfficerGrant/award (A): 70,400 (derivative) @ $0EDGAR
2022-01-254Wooster Richard — DirectorGrant/award (A): 29,200 (derivative) @ $0EDGAR
2022-01-204Tessier Maude — Chief Business OfficerOption exercise (M): 38,915 @ $2.94 · Option exercise (M): 24,606 @ $4.15 · Option exercise (M): 8,265 @ $4.51 · Option exercise (M): 38,915 (derivative) @ $0 · Option exercise (M): 24,606 (derivative) @ $0 · Option exercise (M): 8,265 (derivative) @ $0EDGAR
2022-01-124Zhang Xiaoyan Michelle — Chief Scientific OfficerOption exercise (M): 36 @ $2.15 · Sale (S): 36 @ $12 · Option exercise (M): 964 @ $2.15 · Sale (S): 964 @ $12 · Option exercise (M): 36 (derivative) @ $0 · Option exercise (M): 964 (derivative) @ $0EDGAR
2021-12-234Stampacchia Otello — DirectorGrant/award (A): 13,419 (derivative) @ $0EDGAR
2021-12-234Renaud Ronald C JR — DirectorGrant/award (A): 13,419 (derivative) @ $0EDGAR
2021-12-234FORMELA JEAN FRANCOIS — DirectorGrant/award (A): 13,419 (derivative) @ $0EDGAR

Recent 8-K events — ImageneBio, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-238-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-268-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-178-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-138-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-178-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-03-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-178-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=IKNA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs